Pipeline
At Cephalon, we’re developing therapeutics agents in the areas of central nervous system disorders, inflammatory diseases, oncology, and pain.
Our clinical development program includes small molecules, protein peptides, and biologics in various stages of discovery and development. And, we are working on expanding the indications for some of our existing medicines in an effort to bring these therapies to a greater number of patients in need.
For more information about our portfolio of innovative products, click here.
JEFF VAUGHT, PH.D.
Executive Vice President and Chief Scientific Officer
Research is a marathon, not a sprint. It has taken more than a decade of research, passion and dedication for us to reach this point. But we’re willing to attack complex diseases and invest in products of the future.